Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma

International Journal of Cancer

Volumn 123, Issue 9, 2008, Pages 2105-2112

  Dittmer, Dirk P ^a   Hilscher, Chelsey J ^a   Gulley, Margaret L ^a   Yang, Eric V ^b   Chen, Min ^b   Glaser, Ronald ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Episome; Epithelial cells; Epstein Barr virus; Nasopharyngeal carcinoma; Real time QPCR

Indexed keywords

CIS ACTING ELEMENT; VIRUS DNA;

ARTICLE; CELL CLONE; EPISOME; EPSTEIN BARR VIRUS; GENE DELETION; GENE LOSS; GENE MUTATION; HUMAN; HUMAN CELL; MAMMAL; NASOPHARYNX CARCINOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VIRAL GENETICS; VIRUS CULTURE; VIRUS GENOME; GENE DOSAGE; GENETIC RECOMBINATION; GENETICS; MUTATION; NASOPHARYNX TUMOR; PATHOLOGY; PLASMID; POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIROLOGY;

CELL LINE, TUMOR; DNA, VIRAL; GENE DOSAGE; HERPESVIRUS 4, HUMAN; HUMANS; MUTATION; NASOPHARYNGEAL NEOPLASMS; PLASMIDS; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC;

EID: 51649087471     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23685     Document Type: Article

References (49)

1. Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968;59:94-101.
2. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964;15:702-3.
3. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970;228: 1056-8.
4. Lupton S, Levine AJ. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol cell biol 1985;5:2533-42.
5. Yates J, Warren N, Reisman D, Sugden B. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 1984;81:3806-10.
6. Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985; 313:812-5.
7. Tsai CN, Liu ST, Chang YS. Identification of a novel promoter located within the bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene. DNA Cell Biol 1995;14:767-76.
8. Gu SU, Tann BF, Zeng Y, Zhou WP, Li KB, Zahao MC. Establishment of an epithelial cell line (CNE-2) from an NPC patient with poorly differenciated squamous cell carcinoma. Chin J Cancer 1983; 1:70-72.
9. Huang DP, Ho JH, Poon YF, Chew EC, Saw D, Lui M, Li CL, Mak LS, Lai SH, Lau WH. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer 1980;26:127-32.
10. Yoshiyama H, Imai S, Shimizu N, Takada K. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 1997;71: 5688-91.
11. Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS, Li YP. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA 1989;86:9524-8.
12. Yao KT, Zhang HY, Zhu HC, Wang FX, Li GY, Wen DS, Li YP, Tsai CH, Glaser R. Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas. Int J Cancer 1990;45:83-9.
13. Zhang HY, Yao K, Zhu HC, Glaser R. Expression of the Epstein-Barr virus genome in a nasopharyngeal carcinoma epithelial tumor cell line. Int J Cancer 1990;46:944-9.
14. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006;66:10357-64.
15. Papin J, Vahrson W, Hines-Boykin R, Dittmer DP. Real-time quantitative PCR analysis of viral transcription. Methods Mol Biol 2004; 292:449-80.
16. Rice P, Longden I, Bleasby A. EMBOSS: the european molecular biology open software suite. Trends Genet 2000;16:276-7.
17. Rozen SaHJS. Primer3 Software Distribution. http://frodo.wi.mit.edu/ primer3/primer3_code.html, 1998.
18. Kurokawa M, Ghosh SK, Ramos JC, Mian AM, Toomey NL, Cabral L, Whitby D, Barber GN, Dittmer DP, Harrington WJ, Jr. Azidothymidine inhibits NF-κB and induces Epstein-Barr virus gene expression in Burkitt lymphoma. Blood 2005;106:235-40.
19. Hilscher C, Vahrson W, Dittmer DP. Faster quantitative real-time PCR protocols may lose sensitivity and show increased variability. Nucleic Acids Res 2005;33:e182.
20. Papin J, Vahrson W, Hines-Boykin R, Dittmer DP. Real-time quantitative PCR analysis of viral transcription. Quantifying total viral gene transcription. In: Lieberman P, ed. Methods in molecular virology (DNA viruses). Humana Press, Totowa, NJ; 2004:449-80.
21. Dittmer DP. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res 2003;63:2010-15.
22. Cytogentic ISCoH. An international system for human cytogenetic nomenclature. Basel: Karger, 2005.
23. Seo Y, Stradmann-Bellinghausen B, Rittner C, Takahama K, Schneider PM. Sequence polymorphism of mitochondrial DNA control region in Japanese. Forensic Sci Int 1998;97:155-64.
24. Sato H, Takimoto T, Hatano M, Pagano JS, Raab-Traub N. Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome. J Gen Virol 1989;70:717-27.
25. Knox PG, Li QX, Rickinson AB, Young LS. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma. Virology 1996;215:40-50.
26. Bowtell D, Sambrook J. DNA microarrays: a molecular cloning manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2003.
27. Leight ER, Sugden B. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol 2001;21:4149-61.
28. Yates JL, Guan N. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol 1991;65:483-8.
29. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-8.
30. Broach J. The yeast 2μ circle. In: Strathern J, Jones E, Broach J, eds. The molecular biology of the yeast saccaromyces. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1981:445-70.
31. Robertson ES. Epstein-Barr virus. Norfolk: Caister Academic Press, 2005.
32. Glaser R, Nonoyama M, Hampar B, Croce CM. Studies on the association of the Epstein-Barr virus genome and human chromosomes. J Cell Physiol 1978;96:319-25.
33. Kolman JL, Kolman CJ, Miller G. Marked variation in the size of genomic plasmids among members of a family of related Epstein-Barr viruses. Proc Natl Acad Sci USA 1992;89:7772-6.
34. Shimizu N, Yoshiyama H, Takada K. Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative akata cells. J Virol 1996;70:7260-3.
35. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, Lee JC. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 1999; 83:121-6.
36. Gilligan KJ, Rajadurai P, Lin JC, Busson P, Abdel-Hamid M, Prasad U, Tursz T, Raab-Traub N. Expression of the Epstein-Barr virus BamHI a fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol 1991;65:6252-9.
37. Tomei LD, Noyes I, Blocker D, Holliday J, Glaser R. Phorbol ester and Epstein-Barr virus dependent transformation of normal primary human skin epithelial cells. Nature 1987;329:73-5.
38. Chau CM, Lieberman PM. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 2004;78:12308-19.
39. Bankier AT, Deininger PL, Farrell PJ, Barrell BG. Sequence analysis of the 17,166 base-pair EcoRI fragment C of B95-8 Epstein-Barr virus. Mol Biol Med 1983;1:21-45.
40. Jones MD, Foster L, Sheedy T, Griffin BE. The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. Embo J 1984;3:813-21.
41. Razzouk BI, Srinivas S, Sample CE, Singh V, Sixbey JW. Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma. J Infect Dis 1996;173:529-35.
42. Srinivas SK, Sample JT, Sixbey JW. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line. J Infect Dis 1998;177:1705-9.
43. Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Proc Natl Acad Sci USA 2006;103:14935-40.
44. Kelly GL, Milner AE, Tierney RJ, Croom-Carter DS, Altmann M, Hammerschmidt W, Bell AI, Rickinson AB. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J Virol 2005;79:10709-17.
45. Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT. Epstein-Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol Cell Biol 1999;19:1651-60.
46. An FQ, Folarin HM, Compitello N, Roth J, Gerson SL, McCrae KR, Fakhari FD, Dittmer DP, Renne R. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo. J Virol 2006;80:4833-46.
47. Renne R, Lagunoff M, Zhong W, Ganem D. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 1996;70:8151-4.
48. Herndier BG, Werner A, Arnstein P, Abbey NW, Demartis F, Cohen RL, Shuman MA, Levy JA. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS 1994;8:575-81.
49. Grundhoff A, Ganem D. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 2004;113:124-36.